JP2024538148A5 - - Google Patents
Info
- Publication number
- JP2024538148A5 JP2024538148A5 JP2024522646A JP2024522646A JP2024538148A5 JP 2024538148 A5 JP2024538148 A5 JP 2024538148A5 JP 2024522646 A JP2024522646 A JP 2024522646A JP 2024522646 A JP2024522646 A JP 2024522646A JP 2024538148 A5 JP2024538148 A5 JP 2024538148A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence number
- chain sequence
- heavy chain
- seq
- light chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163256705P | 2021-10-18 | 2021-10-18 | |
| US63/256,705 | 2021-10-18 | ||
| PCT/US2022/078192 WO2023069888A1 (en) | 2021-10-18 | 2022-10-17 | ANTI-EGFR ANTIBODIES, ANTI-cMET ANTIBODIES, ANTI-VEGF ANTIBODIES, MULTISPECIFIC ANTIBODIES, AND USES THEREOF |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024538148A JP2024538148A (ja) | 2024-10-18 |
| JP2024538148A5 true JP2024538148A5 (enExample) | 2025-10-22 |
Family
ID=84267971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522646A Pending JP2024538148A (ja) | 2021-10-18 | 2022-10-17 | 抗ＥＧＦＲ抗体、抗ｃＭＥＴ抗体、抗ＶＥＧＦ抗体、多重特異性抗体及びそれらの使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250230248A1 (enExample) |
| EP (1) | EP4419556A1 (enExample) |
| JP (1) | JP2024538148A (enExample) |
| KR (1) | KR20240099227A (enExample) |
| CN (1) | CN118355030A (enExample) |
| AU (1) | AU2022369278A1 (enExample) |
| CA (1) | CA3232216A1 (enExample) |
| WO (1) | WO2023069888A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4454705A1 (en) * | 2023-04-28 | 2024-10-30 | Jost B. Jonas | Egfr antagonists for the treatment of diseases involving unwanted migration, proliferation, and metaplasia of retinal pigment epithelium (rpe) cells |
| EP4746970A1 (en) * | 2023-09-12 | 2026-05-27 | Jost B. Jonas | Egfr antagonists for the treatment of diseases involving unwanted migration, proliferation, and/or metaplasia of retinal pigment epithelium (rpe) cells |
| IL328594A (en) * | 2023-11-23 | 2026-07-01 | Velavigo Bio Inc | Binding molecule and antibody-drug conjugate and their uses |
| WO2025148868A1 (zh) | 2024-01-08 | 2025-07-17 | 泰励生物科技（上海）有限公司 | 一种抗体偶联药物及其用途 |
| CN118085101A (zh) * | 2024-03-01 | 2024-05-28 | 烟台蓝纳成生物技术有限公司 | 一种二价双特异性抗体、抗体偶联核素药物及其应用 |
| WO2026098440A1 (zh) * | 2024-11-05 | 2026-05-15 | 上海齐鲁制药研究中心有限公司 | 一种双特异性抗体偶联物及其制备方法和应用 |
| WO2026145588A1 (en) * | 2024-12-31 | 2026-07-09 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Use of egfr/c-met bispecific binding protein |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| EP0281604B1 (en) | 1986-09-02 | 1993-03-31 | Enzon Labs Inc. | Single polypeptide chain binding molecules |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| ATE199392T1 (de) | 1992-12-04 | 2001-03-15 | Medical Res Council | Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung |
| AUPO591797A0 (en) | 1997-03-27 | 1997-04-24 | Commonwealth Scientific And Industrial Research Organisation | High avidity polyvalent and polyspecific reagents |
| WO2006028936A2 (en) | 2004-09-02 | 2006-03-16 | Genentech, Inc. | Heteromultimeric molecules |
| KR101374454B1 (ko) | 2005-03-31 | 2014-03-17 | 추가이 세이야쿠 가부시키가이샤 | 회합제어에 의한 폴리펩티드 제조방법 |
| DE102005028778A1 (de) | 2005-06-22 | 2006-12-28 | SUNJÜT Deutschland GmbH | Mehrlagige Folie mit einer Barriere- und einer antistatischen Lage |
| WO2007042289A2 (en) * | 2005-10-11 | 2007-04-19 | Ablynx N.V. | Nanobodies™ and polypeptides against egfr and igf-ir |
| GB0520872D0 (en) * | 2005-10-14 | 2005-11-23 | Hofmann Thomas F | Onion flavour compounds and use |
| WO2007147901A1 (en) | 2006-06-22 | 2007-12-27 | Novo Nordisk A/S | Production of bispecific antibodies |
| CN102361884A (zh) | 2009-04-07 | 2012-02-22 | 罗氏格黎卡特股份公司 | 双特异性抗-ErbB-2/抗-c-Met抗体 |
| US9067986B2 (en) | 2009-04-27 | 2015-06-30 | Oncomed Pharmaceuticals, Inc. | Method for making heteromultimeric molecules |
| CN106046161B (zh) * | 2011-09-30 | 2019-09-13 | 埃博灵克斯股份有限公司 | 与C-Met相关的生物物质 |
| US20170275367A1 (en) | 2012-11-21 | 2017-09-28 | Janssen Biotech, Inc. | Bispecific EGFR/C-Met Antibodies |
| KR102373193B1 (ko) * | 2012-11-21 | 2022-03-10 | 얀센 바이오테크 인코포레이티드 | 이중특이성 EGFR/c-Met 항체 |
| KR102089591B1 (ko) | 2013-07-29 | 2020-03-18 | 삼성전자주식회사 | 항 EGFR scFv 단편 및 이를 포함하는 항 c-Met/항 EGFR 이중 특이 항체 |
| EA033463B1 (ru) | 2014-11-27 | 2019-10-31 | Panasonic Ip Man Co Ltd | Блок стеклянных панелей |
| JP2019500011A (ja) | 2015-11-03 | 2019-01-10 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | 腫瘍選択性及び阻害性が増強された二重特異性抗体及びその使用 |
| EP4592313A3 (en) * | 2019-03-05 | 2025-11-19 | Takeda Pharmaceutical Company Limited | Constrained conditionally activated binding proteins |
-
2022
- 2022-10-17 CN CN202280070414.4A patent/CN118355030A/zh active Pending
- 2022-10-17 JP JP2024522646A patent/JP2024538148A/ja active Pending
- 2022-10-17 AU AU2022369278A patent/AU2022369278A1/en active Pending
- 2022-10-17 KR KR1020247014165A patent/KR20240099227A/ko active Pending
- 2022-10-17 CA CA3232216A patent/CA3232216A1/en active Pending
- 2022-10-17 US US18/701,582 patent/US20250230248A1/en active Pending
- 2022-10-17 EP EP22800983.3A patent/EP4419556A1/en active Pending
- 2022-10-17 WO PCT/US2022/078192 patent/WO2023069888A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021514664A5 (enExample) | ||
| JP2022526764A5 (enExample) | ||
| JP2021526022A5 (enExample) | ||
| IL276830B1 (en) | Anti-claudin 18.2 antibodies and their uses | |
| KR102078292B1 (ko) | 신규한 항 c-Met 항체 및 이의 용도 | |
| JP2024531409A5 (enExample) | ||
| HRP20192038T1 (hr) | Protutijela receptora anti-epidermalnog faktora rasta (egfr) | |
| JP2020501598A5 (enExample) | ||
| JP2017149720A5 (enExample) | ||
| JP2017514461A5 (enExample) | ||
| JP2023546743A5 (enExample) | ||
| CN114761433B (zh) | 一种抗Claudin18.2单克隆抗体、其制备方法及用途 | |
| JP2022533538A5 (enExample) | ||
| JP2020522281A5 (enExample) | ||
| JP2021528400A5 (enExample) | ||
| JP2020522280A5 (enExample) | ||
| JP2017521054A5 (enExample) | ||
| AU2020447878A1 (en) | Anti-CD73 antibody and use thereof | |
| JP2025501775A5 (enExample) | ||
| JP2021517459A5 (enExample) | ||
| JP2024024114A5 (enExample) | ||
| JP2024540148A5 (enExample) | ||
| JP2021512652A5 (enExample) | ||
| TW202241944A (zh) | 新穎的抗ｇｒｅｍｌｉｎ１抗體 | |
| JP2018528759A5 (enExample) |